Despite its negative effects on plasmin activity via PAI-1, TGF-β has been reported to enhance tumor cell migration independently from SMADs, by remodeling cytoskeleton via monomeric G proteins of the rho/rac family (Tsai et al. 2014; Ungefroren et al. 2018). This evidence concerns the gene TGFB1 and neoplasm.